Breast cancer is the most common malignant tumor in ...

Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351; 1451-1467, 1998 . Phase 111 study of Letrozole versus tamoxifen as first line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole breast Cancer … ................
................